Mulmit

PRECISION BIOSCIENCES INCPRECISION BIOSCIENCES INC

DTIL Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3134,264,000-52,148,000-45,724,000-3.56
2024-12-3168,696,000-26,162,0007,167,0001.04
2023-12-3148,727,000-43,736,000-61,319,000-15.96
2022-12-3125,098,000-62,308,000-111,637,000-38.1
2021-12-31115,529,000-39,376,000-30,602,000-0.52

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-03Brown Melinda20,979
2026-06-03Frankel Stanley20,979
2026-06-03Germano Geno J20,979
2026-06-03Pire Shari Lisa20,979
2026-06-03Buehler Kevin20,979
2026-06-01SMITH J. JEFFERSONChief Research Officer57,389
2026-06-01Scimeca DarioGeneral Counsel and Secretary107,604
2026-06-01Kelly John AlexanderChief Financial Officer193,688
2026-06-01Amoroso MichaelPresident and CEO573,888
2026-05-20Buehler Kevin21,000
2026-05-20Buehler Kevin21,000
2026-05-20Frankel Stanley21,000

8-K events

FiledItems
2026-08-24Regulation FD disclosure · Other events · Financial statements and exhibits
2026-08-06Results of operations · Financial statements and exhibits
2026-07-27Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2026-07-01Regulation FD disclosure · Other events · Financial statements and exhibits
2026-06-16Entry into a material agreement · Creation of a direct financial obligation · Financial statements and exhibits
2026-05-27Regulation FD disclosure · Other events · Financial statements and exhibits
2026-05-26Officer or director change · Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-05-05Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.